ScholarIQanswers from OpenAlex & ORCID
Mark G. Kris
ResearcherPublications, citations & collaboration network
Mark G. Kris is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Mark G. Kris have?
ScholarIQindexed works
Mark G. Kris has 1,388 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Mark G. Kris have?
ScholarIQcitation count
Mark G. Kris has 102,485 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Mark G. Kris?
ScholarIQh-index
Mark G. Kris has an h-index of 149 in OpenAlex.
What is the i10-index of Mark G. Kris?
ScholarIQi10-index
Mark G. Kris has an i10-index of 539 in OpenAlex.
What is the ORCID of Mark G. Kris?
ScholarIQorcid
The ORCID for Mark G. Kris is on the source record.
What is the OpenAlex record for Mark G. Kris?
ScholarIQopenalex
The OpenAlex for Mark G. Kris is on the source record.
What are the most-cited papers on Mark G. Kris?
ScholarIQmost cited works
EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
William Pao, Vincent A. Miller, Maureen F. Zakowski, Jennifer A. Doherty, Katerina Politi, Inderpal S. Sarkaria, Bhuvanesh Singh, Robert T. Heelan, Valerie W. Rusch, Lucinda A. Fulton, Elaine R. Mardis, Doris M. Kupfer, Richard K. Wilson, Mark G. Kris, Harold Varmus
Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain
William Pao, Vincent A. Miller, Katerina Politi, Gregory J. Riely, Romel Somwar, Maureen F. Zakowski, Mark G. Kris, Harold Varmus
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
Ethan Basch, Allison M. Deal, Mark G. Kris, Howard I. Scher, Clifford A. Hudis, Paul Sabbatini, Lauren J. Rogak, Antonia V. Bennett, Amylou C. Dueck, Thomas M. Atkinson, Joanne F. Chou, Dorothy Dulko, Laura Sit, Allison Barz Leahy, Paul J. Novotny, M. Fruscione, Jeff A. Sloan, Deborah Schrag
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
Mark G. Kris, Ronald B. Natale, Roy S. Herbst, T. J. Lynch, Diane Prager, Chandra P. Belani, Joan H. Schiller, Karen Kelly, H. Spiridonidis, Alan Sandler, Kathy S. Albain, David Cella, Michael Wolf, Steven D. Averbuch, Judith Ochs, Andrea Kay
Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with <i>EGFR</i> -Mutant Lung Cancers
Helena A. Yu, Maria E. Arcila, Natasha Rekhtman, Camelia S. Sima, Maureen F. Zakowski, William Pao, Mark G. Kris, Vincent A. Miller, Marc Ladanyi, Gregory J. Riely